aminopeptidas
ap
constitut
group
exopeptidas
close
relat
activ
abl
remov
aminoacid
unblock
ntermini
peptid
protein
substrat
among
metalloaminopeptidas
metalloap
wide
distribut
organ
repres
member
anim
cell
plant
cell
fungi
parasit
bacteria
metalloap
broadli
sort
two
import
subgroup
basi
number
zinc
ion
activ
site
involv
catalysi
well
protein
signatur
fold
enzym
contain
one
zinc
other
possess
binuclear
metal
centr
usual
refer
cocatalyt
unit
member
famili
belong
subclan
e
metallopeptidas
also
call
gluzincin
possess
singl
essenti
catalyt
zinc
ion
common
fold
relat
common
ancestri
relat
thermolysin
present
mainli
monom
homodim
mammal
mainli
metalloap
occupi
variou
cell
compart
although
secret
vast
major
oper
membran
bound
ectoenzym
cytosol
catalyst
evolutionari
histori
indic
relat
complex
ancestr
gene
famili
subsequ
yield
seri
diverg
sequenc
reason
biochem
character
respect
biolog
import
long
time
hinder
consider
confus
due
part
often
larg
sometim
overlap
substrat
specif
well
close
biochem
properti
time
precis
pictur
highli
special
role
depend
local
mani
relat
paralog
member
mammal
h
sapien
rodent
wherea
hand
known
encod
speci
less
one
p
falciparum
human
paralog
member
name
leucylcystinyl
aminopeptidas
hsirap
endoplasm
reticulum
aminopeptidas
endoplasm
reticulum
aminopeptidas
aminopeptidas
q
hsapq
puromycinsensit
aminopeptidas
hspsa
thyrotropinreleas
hormonedegrad
ectoenzym
hstrhde
aminopeptidas
hsapa
aminopeptidas
n
hsapn
aminopeptidas
hsapo
leukotrien
hydrolas
arginyl
aminopeptidas
b
hsapb
arginyl
aminopeptidas
b
like
orthologu
e
coli
ecpepn
p
falciparum
far
recogn
biolog
implic
summar
tabl
broadli
human
member
play
import
biolog
role
reninangiotensin
system
immun
system
well
inflammatori
process
bacteri
malari
member
involv
nutrient
acquisit
consequ
definit
famili
member
merop
databas
far
identifi
amino
acid
sequenc
belong
famili
share
critic
characterist
sequenc
align
select
aminopeptidas
highlight
conserv
activ
site
residu
substrat
recognit
peptid
bond
hydrolysi
zinc
bind
motif
substrat
bind
motif
includ
gxmen
domain
extra
e
q
distal
residu
respons
recognit
bind
key
free
amino
terminu
peptid
substrat
well
catalyt
e
residu
part
hexxh
motif
distal
residu
essenti
transit
state
stabil
close
conform
aminopeptidas
figur
although
overal
amino
acid
sequenc
similar
may
fall
mean
valu
highli
conserv
structur
remind
seahors
domain
found
ap
domain
fold
twist
aa
domain
ii
correspond
ancestr
thermolysinlik
fold
domain
iii
beta
sandwich
built
absent
domain
iv
promin
bowllik
structur
compos
aa
contain
activ
site
channel
entranc
long
larg
dynam
conform
ensembl
involv
interdomain
movement
crucial
catalysi
variou
conform
state
particularli
mark
mammalian
enzym
includ
activ
site
open
closur
particularli
import
hsirap
mammalian
apn
suggest
peptidebind
channel
could
accommod
various
expos
ntermini
peptid
andor
protein
influenc
protein
dimer
activ
site
access
specif
well
variou
moonlight
function
still
extens
studi
famili
ap
substrat
specif
also
respons
confus
biolog
role
attribut
enzym
illustr
tabl
substrat
specif
rare
discrimin
overlap
specif
rule
specif
specif
rare
except
common
substrat
specif
togeth
conserv
structur
catalyt
mechan
make
develop
highli
select
inhibitor
given
metalloaminopeptidas
obvious
challeng
therebi
notabl
inhibitor
depict
figur
consist
tetrahedr
intermedi
mimic
wide
use
bestatin
phosphin
phosphon
acid
deriv
zincchel
group
insert
peptidelik
scaffold
hydroxam
acid
tabl
report
inhibit
valu
sever
member
aminopeptidas
famili
three
select
bimetal
aminopeptidas
sinc
select
toward
metalloaminopeptidas
remain
major
concern
inde
current
poorli
document
inhibitor
target
mammalian
apn
extens
develop
sinc
mammalian
apn
one
first
metalloaminopeptidas
biochem
enzymat
character
although
mani
first
assign
biolog
function
later
demonstr
involv
relat
paralog
enzym
among
bestatin
often
misus
specif
inhibitor
peculiar
apn
enzym
sinc
turn
highli
potent
inhibitor
bimetal
enzym
famili
quit
broad
unspecif
inhibitor
monometal
aminopeptidas
overal
appear
obviou
develop
aminopeptidas
inhibitor
remain
mainli
infanc
research
group
previous
report
develop
potent
select
inhibitor
apn
human
aminopeptidas
involv
angiogenesi
tumour
metastasi
work
allow
us
identifi
aminobenzosuberon
moieti
promis
scaffold
demonstr
except
select
toward
monometal
aminopeptidas
present
work
close
consid
evalu
inhibitor
number
potenti
interest
target
within
famili
aminopeptidas
establish
inhibit
profil
report
herein
improv
aminobenzosuberon
synthet
rout
biolog
evalu
famili
nonpeptid
compound
human
bacterialparasit
aminopeptidas
plu
member
famili
also
verifi
observ
select
panel
proteinas
includ
repres
member
aspart
cystein
metallo
serin
endopeptidas
aminobenzosuberon
synthet
rout
base
previous
describ
procedur
optim
improv
reproduc
avoid
appear
sideproduct
scheme
inde
silyl
enol
ether
obtain
four
step
commerci
avail
product
submit
rubottom
oxid
yield
key
intermedi
silyloxyketon
reaction
classic
perform
action
mcpba
regular
unpredict
failur
reagent
led
us
consid
altern
oxid
agent
best
result
obtain
situ
gener
dimethyl
dioxiran
dmdo
gave
expect
product
nearli
quantit
reproduc
yield
second
optim
step
convers
hydroxyoxim
correspond
aminoalcohol
previous
describ
method
reduct
consist
hydrogen
raney
nickel
although
procedur
work
effici
depend
qualiti
suppli
raney
nickel
moreov
case
bromin
compound
requir
care
monitor
avoid
aromat
debromin
thu
sever
condit
investig
obtain
compound
mgammonium
format
promis
result
obtain
latter
small
amount
debromin
product
still
observ
therefor
addit
success
replac
addit
expect
amino
compound
sole
obtain
effect
aromat
bromin
even
without
strict
monitor
reaction
progress
accept
yield
confirm
extend
outstand
select
aminobenzosuberon
deriv
aminopeptidas
class
proteinas
aspart
cystein
metallo
serin
endopeptidas
valu
test
case
tabl
expect
bimetal
aminopeptidas
aap
famili
weakli
inhibit
test
compound
tabl
among
aminopeptidas
potent
inhibitori
valu
remain
mammalian
apn
subnanomolar
ki
valu
compound
ki
pm
note
inhibit
lowmolecular
weight
scaffold
except
ki
sar
determin
mammalian
apn
similar
orthologu
microorgan
ecpepn
p
falciparum
improv
affin
aminobenzosuberon
scaffold
substitut
posit
hydrophob
function
group
instanc
exhibit
ki
valu
nm
nm
ecpepn
respect
influenc
bromin
posit
remain
similar
enzym
microorgan
fold
increas
potenc
compar
unsubstitut
deriv
main
differ
reli
lack
synergist
effect
potent
apn
posit
occupi
function
ph
andor
br
compound
show
similar
potenc
ki
valu
nm
nm
respect
time
potent
ecpepn
regard
human
enzym
hspsa
wellinhibit
ki
valu
nm
respect
within
oxytocinas
subfamili
compound
less
activ
inhibitori
potenc
micromolar
rang
except
hsirap
ki
nm
gener
inhibitor
less
potent
even
similar
trend
emerg
sar
studi
actual
substitut
posit
seem
effici
substitut
posit
usual
potent
deriv
display
interest
bind
affin
precis
substitut
pattern
achiev
excel
potenc
present
work
focus
subtl
amino
acid
sequenc
differ
activ
site
may
explain
variou
inhibit
valu
experiment
determin
select
aminopeptidas
addit
conform
dynam
consid
member
famili
among
structur
captur
variou
crystal
process
data
remain
scarc
due
small
number
solv
structur
gener
statement
could
outlin
nevertheless
sar
studi
enabl
precis
structur
environ
requir
potent
inhibit
aminobenzosuberon
deriv
given
enzym
within
famili
discuss
essenti
focu
close
conform
differ
aminopeptidas
determin
structur
variou
speci
indic
activ
site
aminopeptidas
buri
insid
protein
zinc
bind
site
may
locat
spaciou
caviti
wide
open
locat
small
gate
compart
case
bacterialparasit
orthologu
agreement
activ
site
caviti
volum
differ
aminopeptidas
analys
kvfinder
tabl
figur
local
intradomaininterdomain
movement
caus
enlarg
contract
activ
site
encount
ecpepn
mammalian
apn
howev
architectur
amino
acid
composit
activ
site
highli
conserv
within
whole
famili
permit
predict
ident
bind
mode
aminobenzosuberon
ligand
variou
aminopeptidas
similar
previou
model
report
mammalian
apn
ecpepnaminobenzosuberon
cocrystal
structur
figur
subsit
alway
describ
cylind
form
hydrophob
residu
cap
two
polar
amino
acid
tabl
key
residu
constitut
recognit
site
summar
interestingli
highli
variabl
residu
highlight
red
steric
size
polar
locat
entranc
pocket
may
contribut
divers
specif
tabl
figur
aforement
variabl
residu
may
flexibl
upon
ligand
bind
might
steric
hinder
restrict
thu
subsit
entranc
figur
detail
figur
instanc
ecpepn
correspond
pdb
temperatur
factor
valu
agreement
local
signific
flexibl
side
chain
act
cushion
accommod
variou
side
chain
posit
substrateligand
local
movement
met
residu
caus
contract
activ
site
caviti
kvfinder
analysi
reveal
caviti
volum
ecpepnbestatin
complex
pdb
higher
compar
ecpepnaminobenzuberon
complex
pdb
tabl
latter
complex
residu
found
two
close
posit
move
slightli
inward
subsit
interrupt
shorten
typic
cylindr
shape
distanc
sulphur
atom
centroid
aromat
ring
aminobenzosuberon
scaffold
consist
sulphurcarbon
van
der
waal
contact
sulphur
lone
pair
might
interact
edg
aromat
core
provid
addit
stabil
figur
hand
pdb
pdb
might
consid
straight
bulki
shorten
pocket
pdb
posit
induc
format
narrow
tunnel
moreov
domain
iii
miss
latter
enzym
presenc
particularli
extend
activ
site
caviti
point
inward
toward
zn
ion
reduc
substanti
activ
site
caviti
volum
figur
result
spatial
arrang
steric
clash
aromat
core
aminobenzosuberon
might
explain
weak
inhibitori
activ
scaffold
aminobenzosuberon
deriv
markedli
potent
aminopeptidas
exhibit
shallow
caviti
small
moder
size
ecpepn
hsapn
borderlin
case
hsirap
top
elong
subsit
cylind
locat
two
three
cap
residu
present
bold
type
tabl
depict
stick
figur
figur
ctermin
domain
protein
residu
known
influenc
subsit
specif
inde
depend
natur
residu
conform
flexibl
side
chain
mitig
potenti
unfavour
steric
clash
favour
van
der
waal
hbond
electrostat
interact
substratesinhibitor
moreov
close
subsit
induc
expuls
water
molecul
activ
site
bulk
entrop
favour
may
strengthen
van
der
waal
electrostat
interact
analysi
superimpos
structur
show
aminobenzosuberon
inhibitor
expect
penetr
caviti
deepli
inhibitor
like
bestatin
figur
figur
indic
therefor
interact
effici
shallow
subsit
howev
depend
natur
variabl
amino
acid
residu
aminobenzosuberon
core
might
slightli
move
upward
minim
potenti
steric
hindranc
special
gatekeep
residu
substitu
like
induc
steric
conflict
residu
entranc
caviti
suitabl
substitut
offer
new
scope
novel
seri
potent
select
aminobenzosuberon
deriv
figur
contrast
subsit
open
caviti
residu
enzym
instanc
ecpepn
compos
subsit
care
analysi
variou
structur
show
residu
highlight
blue
red
tabl
seem
involv
plastic
therebi
control
caviti
width
depth
figur
figur
two
amino
acid
locat
sidewal
opposit
catalyt
zinc
ion
partial
cap
caviti
ecpepn
vari
size
polar
within
enzym
famili
summar
tabl
figur
exampl
found
buri
caviti
hsapn
reduc
thu
slightli
width
subsit
wherea
ecpepn
hsapn
posit
similar
locat
modifi
therebi
local
polar
also
ecpepn
side
chain
locat
insid
caviti
reduc
caviti
depth
wherea
less
bulki
polar
hsapn
occupi
similar
posit
final
local
flexibl
observ
within
captur
structur
inde
side
chain
residu
hsapn
ecpepn
adopt
differ
posit
upon
ligand
bind
similar
observ
might
also
notic
ecpepn
carboxyl
side
chain
either
orient
outsid
caviti
insid
orient
potenti
involv
interact
exemplifi
n
meningitid
alanyl
aminopeptidas
inhibit
studi
close
vicin
ly
residu
found
respect
side
chain
extend
caviti
residu
black
bold
figur
develop
interact
particular
residu
via
para
metasubstitut
phenyl
ring
posit
aminobenzosuberon
core
improv
select
affin
member
oxytocinas
famili
inform
clarifi
inhibit
observ
hsapn
microbi
orthologu
ecpepn
despit
caviti
volum
slightli
larger
hsapn
ecpepn
tabl
subsit
caviti
width
shorter
lead
lack
bind
affin
bulki
ferrocenyl
substitu
fit
appropri
subsit
ki
regard
sar
experiment
determin
highlight
import
substitut
aminobenzosuberon
core
accord
model
almost
fulli
occupi
subsit
evalu
enzym
aminopeptidas
accommod
bromin
phenyl
group
improv
affin
inhibitor
compar
unsubstitut
deriv
nevertheless
phenyl
group
mostli
prefer
probabl
due
possibl
ecpepn
lead
low
ki
valu
compar
import
featur
consid
aminopeptidas
molecular
recognit
inter
intradomain
movement
variou
conform
captur
crystal
process
open
intermedi
close
conform
determin
variou
given
enzym
suggest
dynam
import
ligand
bind
peptid
hydrolysi
larg
interdomain
motion
markedli
observ
associ
local
chang
highli
conserv
tyr
residu
activ
site
correspond
posit
ecpepn
figur
open
form
protein
residu
undergo
shift
away
zinc
ion
wherea
close
form
tyr
residu
propos
assist
activ
peptid
bond
stabil
tetrahedr
intermedi
proteolyt
catalyt
cycl
shown
site
direct
mutagenesi
mutat
tyr
residu
phe
complet
abolish
enzym
activ
result
dynam
open
form
enzym
like
catalyt
inact
subsequ
alloster
activ
upon
substrat
bind
might
trigger
catalyt
activ
close
form
dynam
transit
differ
state
might
help
substratesproduct
bind
releas
activ
site
solut
number
conform
might
exist
open
close
state
along
differ
posit
tyr
residu
previous
suggest
tyr
residu
probabl
activ
carbonyl
function
aminobenzosuberon
toward
nucleophil
attack
catalyt
water
form
hydrat
form
keton
function
gener
situ
potent
chelat
zinc
ion
perfect
mimic
transit
state
lowmolecular
weight
revers
inhibitor
would
like
bind
close
form
optimum
interact
interestingli
hsirap
report
undergo
similar
conform
chang
time
complet
differ
orient
gamen
motif
upon
inhibitor
bind
lead
close
conform
hsirap
pdb
highlight
signific
structur
plastic
gamen
loop
sinc
enzym
solut
exist
conform
equilibrium
differ
form
even
small
angl
xray
scatter
experi
suggest
averag
structur
solut
adopt
open
conform
process
could
account
moder
inhibit
activ
valu
observ
hserap
subfamili
lesser
extent
hsirap
indic
aminobenzosuberon
scaffold
abl
induc
domain
movement
close
form
enzym
intradomain
mobil
also
consid
exampl
besid
compact
fold
particular
human
porcin
apn
structur
determin
plastic
subsit
conform
chang
look
like
smallshallow
hydrophob
pocket
compar
deeper
subsit
observ
crystal
aminopeptidas
inde
hsapn
serv
cap
pocket
belong
flexibl
loop
indic
averag
temperatur
factor
residu
domain
iv
might
act
gatekeep
restrict
access
close
subsit
upon
ligand
bind
pocket
might
undergo
major
conform
chang
via
movement
flexibl
loop
reveal
thu
deeper
cylindr
hydrophob
subsit
caviti
volum
activ
site
hsapn
vari
figur
tabl
seri
compound
potent
human
enzym
probabl
interact
phein
conform
loop
via
bromin
substitu
aminobenzosuberon
core
aromat
ring
ki
pm
interact
might
induc
stabil
closur
domain
iv
especi
mammalian
apn
henc
close
apn
form
import
featur
block
porcin
coronaviru
cell
entri
via
porcin
apn
receptor
differ
conform
dynam
process
seem
import
aspect
catalyt
regul
enzym
although
yet
document
larger
number
structur
inter
intradomain
movement
probabl
one
remark
featur
aminopeptidas
dynam
accord
biolog
function
cellular
local
gain
insight
physicochem
admetox
properti
aminobenzosuberon
deriv
sever
paramet
experiment
determin
comput
tabl
experiment
valu
whole
aminobenzosuberon
seri
compli
lipinski
rule
five
calcul
tpsa
valu
compris
keton
hydrat
form
respect
compound
predict
penetr
bloodbrain
barrier
although
possibl
pglycoprotein
pgp
efflux
issu
taken
consider
predict
probabl
pgp
substrat
could
consid
valuabl
chemic
tool
target
aminopeptidas
implic
cn
diseas
mostli
involv
brain
reninangiotensin
system
hsirap
hsapn
hsapa
pain
manag
hsapn
howev
aminobenzosuberon
scaffold
requir
care
optim
increas
select
toward
target
aminopeptidas
versu
hspsa
play
major
neuroprotect
role
analysi
calcul
probabl
drugdrug
interact
differ
isozym
show
seri
molecul
inhibit
lesser
extent
addit
probabl
toxic
high
mostli
associ
cardiotox
inhibit
herg
channel
also
hepatotox
uncertainti
predict
outcom
taken
account
potenti
toxic
liabil
investig
thu
consid
admet
properti
inhibitori
activ
promis
compound
subsequ
studi
deriv
also
synthet
feasibl
molecul
howev
accord
predict
method
decreas
liphol
clogp
ou
introduc
heteroatom
phenyl
ring
compound
might
also
direct
modif
sinc
improv
adm
properti
benefici
effect
toxic
reactant
purchas
usual
provid
usual
solvent
freshli
distil
dri
meoh
distil
dri
dme
na
benzophenon
dri
distil
store
na
dcm
distil
store
anhydr
flash
chromatographi
silica
gel
merck
mesh
tlc
alrol
silica
gel
merck
mp
kofler
hot
bench
correct
mhz
mhz
resp
spectra
bruker
avanc
ppm
j
hertz
racem
substitut
hydrochlorid
salt
alreadi
fulli
describ
literatur
resynthes
determin
select
profil
inhibitori
activ
papn
aap
alreadi
report
icecold
mixtur
water
aceton
ml
ad
g
eq
g
eq
suspens
stir
min
solut
silyl
enol
ether
g
eq
dcm
ml
dropwis
ad
mixtur
warm
rt
stir
h
tlc
monitor
layer
separ
aqueou
layer
extract
dcm
combin
organ
layer
wash
brine
dri
filter
concentr
give
silyloxi
keton
use
without
purif
solut
hydroxyoxim
mg
eq
methanol
ml
ad
mg
eq
mixtur
cool
mg
eq
care
ad
reaction
slowli
warm
rt
stir
h
tlc
monitor
mixtur
dilut
water
extract
acoet
organ
layer
wash
brine
dri
filter
concentr
give
aminoalcohol
nprotect
without
purif
gene
encod
residu
nativ
plasmodium
falciparum
alanyl
aminopeptidas
plasmodb
residu
nativ
plasmodium
falciparum
leucyl
aminopeptidas
plasmodb
synthet
genecust
luxembourg
help
algorithm
develop
optim
dna
sequenc
improv
protein
express
escherichia
coli
isynthet
gene
clone
express
vector
novagen
append
ntermin
hexahistidin
tag
knpi
sali
site
sali
site
escherichia
coli
rosetta
bacteria
novagen
transform
recombin
plasmid
valid
sanger
sequenc
beckman
coulter
genom
bacteri
cultur
grown
autoinduc
lb
medium
merck
supplement
carbenicillin
chloramphenicol
h
prior
bacteri
extract
prepar
bugbustertm
novagen
darmstadt
germani
clarifi
lysat
load
onto
histrap
column
ge
healthcar
equilibr
mm
imidazol
phosphat
buffer
wash
buffer
bound
recombin
protein
elut
mm
imidazol
mm
imidazol
phosphat
buffer
elut
fraction
final
purifi
size
exclus
chromatographi
superdex
equilibr
tri
hcl
mm
nacl
mm
ph
hepe
mm
nacl
mm
glycerol
ph
use
purifi
chromatographi
system
ge
healthcar
life
scienc
littl
chalfont
england
express
purif
recombin
human
endoplasm
reticulum
aminopeptidas
endoplasm
reticulum
aminopeptidas
insulinregul
aminopeptidas
hsirap
describ
briefli
recombin
baculoviru
contain
gene
enzym
produc
cell
accord
manufactur
instruct
bactobac
baculoviru
express
system
invitrogen
recombin
protein
express
cell
infect
appropri
recombin
baculoviru
purifi
ninta
affin
chromatographi
previous
describ
pmid
protein
aliquot
store
buffer
contain
mm
hepe
ph
mm
nacl
glycerol
need
enzym
purifi
report
earlier
test
carri
hpagil
uvvis
diod
array
spectrophotomet
hpagil
santa
clara
ca
usa
tri
hcl
mm
ph
ph
final
dmso
concentr
enzym
activ
nm
nm
determin
continu
measur
releas
paranitroanilin
nm
alanin
paranitroanilid
substrat
km
mm
leucin
paranitroanilid
km
mm
min
incub
measur
conduct
min
h
initi
veloc
measur
increas
concentr
inhibitor
ki
valu
determin
dixon
plot
triplic
sigma
use
measur
activ
protein
releas
alanin
paranitroanilid
nm
km
mm
experi
perform
hpagil
uvvis
diod
array
spectrophotomet
min
tri
hcl
mm
kcl
mm
ph
obtain
valu
enzym
activ
assay
carri
mm
trishcl
buffer
ph
mm
nacl
enzym
substrat
leupna
reaction
absorb
read
nm
concentr
rang
nm
inhibitor
dissolv
dmso
incub
enzym
ecpepn
hspsa
min
well
plate
addit
substrat
immedi
increas
absorpt
measur
inhibit
assay
perform
triplic
initi
veloc
measur
percentag
inhibit
log
valu
inhibitor
concentr
plot
use
sigmaplot
determin
valu
ki
valu
determin
dixon
method
assay
consist
reaction
buffer
enzym
vari
concentr
leupna
base
valu
substrat
concentr
inhibitor
concentr
vari
rang
nm
nm
data
plot
versu
inhibitor
concentr
substrat
concentr
linear
fit
calcul
nonlinear
regress
use
reaction
perform
triplic
sd
valu
report
enzymat
activ
hsirap
determin
follow
timedepend
increas
fluoresc
nm
excit
nm
fluorigen
substrat
coumarin
lamc
sigma
darmstatd
germani
hsirap
coumarin
ramc
sigma
measur
perform
plate
total
volum
well
tecan
infinit
micropl
fluoresc
reader
nm
nm
nm
hsirap
ad
well
along
substrat
vari
concentr
compound
within
rang
nm
reaction
follow
min
room
temperatur
remain
enzymat
activ
calcul
measur
slope
time
cours
calcul
vitro
valu
experiment
data
fit
follow
equat
use
graphpad
prism
softwar
packag
bottom
top
bottom
x
hillslop
enzymat
activ
x
inhibitor
concentr
lipophil
valu
aminobenzosuberon
determin
reversedphas
hplc
column
eclips
mm
agil
franc
accord
method
previous
describ
minick
pomper
measur
chromatograph
capac
factor
compound
done
variou
concentr
rang
methanol
contain
octanol
aqueou
phase
consist
ndecylamin
mop
nmorpholino
propanesulfon
acid
buffer
ph
prepar
water
flow
mlmin
aminobenzosuberon
deriv
dissolv
methanol
standard
also
dissolv
methanol
column
void
volum
estim
retent
time
uracil
includ
nonretain
intern
refer
inject
capac
factor
extrapol
aqueou
compon
given
valu
obtain
formula
posit
control
experiment
n
literatur
valu
studi
admet
properti
carri
websit
http
admetscbddcom
famili
aminopeptidas
broad
overlap
substrat
specif
henc
smallmolecul
inhibitor
may
alway
specif
especi
regard
select
toward
bimetal
enzym
aminobenzosuberon
scaffold
demonstr
exclus
select
monometal
aminopeptidas
famili
particular
potent
inhibitori
activ
mammalian
apn
microbi
orthologu
ecpepn
ki
valu
nanomolar
rang
retain
interest
potenc
hspsa
also
hsirap
ki
valu
nano
submicromolar
rang
seemingli
less
activ
oxytocinas
enzym
valu
micromolar
rang
total
inact
promis
scaffold
repres
attract
new
class
potent
antimalari
compound
target
crucial
enzym
involv
least
last
commit
step
haemoglobin
degrad
plasmodium
falciparum
addit
grow
evid
highlight
crucial
role
play
mammalian
aminopeptidas
great
varieti
cancer
type
especi
hsapn
via
proteolyt
activ
abil
modul
proteinprotein
interact
aminobenzosuberon
core
attract
start
point
design
tripl
inhibitor
three
enzym
act
interf
endotheli
cell
morphogenesi
cell
motil
modul
antigen
process
trigger
cancer
immunotherapi
next
challeng
ration
design
select
inhibitor
individu
aminopeptidas
studi
biolog
role
precis
function
avoid
potenti
advers
effect
follow
vivo
treatment
aminobenzosuberon
deriv
target
member
divers
famili
achiev
goal
design
process
effort
take
account
plastic
activ
site
conform
dynam
aminopeptidas
interest
hint
suggest
deeper
interact
subsit
substitut
scaffold
offer
new
opportun
improv
activ
select
anoth
approach
achiev
select
look
cellularsubcellular
local
andor
tissu
distribut
target
aminopeptidas
design
targetedprodrug
improv
sitespecif
drug
deliveri
differ
strategi
current
investig
report
due
cours
